IE63418B1 - Progression risk of HIV by assay of dehydroepiandrosterone in body fluid - Google Patents
Progression risk of HIV by assay of dehydroepiandrosterone in body fluidInfo
- Publication number
- IE63418B1 IE63418B1 IE326690A IE326690A IE63418B1 IE 63418 B1 IE63418 B1 IE 63418B1 IE 326690 A IE326690 A IE 326690A IE 326690 A IE326690 A IE 326690A IE 63418 B1 IE63418 B1 IE 63418B1
- Authority
- IE
- Ireland
- Prior art keywords
- dhea
- body fluid
- amount
- sample
- hiv
- Prior art date
Links
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 title claims abstract description 73
- 210000001124 body fluid Anatomy 0.000 title claims description 16
- 239000010839 body fluid Substances 0.000 title claims description 16
- FMGSKLZLMKYGDP-UHFFFAOYSA-N Dehydroepiandrosterone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CC=C21 FMGSKLZLMKYGDP-UHFFFAOYSA-N 0.000 title description 48
- 229960002847 prasterone Drugs 0.000 title description 48
- 238000003556 assay Methods 0.000 title description 8
- 238000000034 method Methods 0.000 claims abstract description 31
- 208000031886 HIV Infections Diseases 0.000 claims abstract description 13
- 208000037357 HIV infectious disease Diseases 0.000 claims abstract description 12
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims abstract description 12
- 230000028327 secretion Effects 0.000 claims abstract description 9
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- 238000003018 immunoassay Methods 0.000 claims description 11
- 210000002966 serum Anatomy 0.000 claims description 8
- 210000004369 blood Anatomy 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 210000004027 cell Anatomy 0.000 claims description 5
- 238000001030 gas--liquid chromatography Methods 0.000 claims description 5
- 230000000984 immunochemical effect Effects 0.000 claims description 5
- 210000004698 lymphocyte Anatomy 0.000 claims description 4
- 238000003127 radioimmunoassay Methods 0.000 claims description 4
- 108060003951 Immunoglobulin Proteins 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 230000002255 enzymatic effect Effects 0.000 claims description 3
- 102000018358 immunoglobulin Human genes 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 238000001262 western blot Methods 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 abstract 1
- 208000030507 AIDS Diseases 0.000 description 14
- 239000000523 sample Substances 0.000 description 11
- 241000725303 Human immunodeficiency virus Species 0.000 description 10
- 102000003992 Peroxidases Human genes 0.000 description 7
- 108040007629 peroxidase activity proteins Proteins 0.000 description 7
- 239000011324 bead Substances 0.000 description 5
- 238000005534 hematocrit Methods 0.000 description 5
- 208000035473 Communicable disease Diseases 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- CZWCKYRVOZZJNM-USOAJAOKSA-N dehydroepiandrosterone sulfate Chemical compound C1[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 CZWCKYRVOZZJNM-USOAJAOKSA-N 0.000 description 3
- 230000000652 homosexual effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000005497 microtitration Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229950009829 prasterone sulfate Drugs 0.000 description 3
- 208000010648 susceptibility to HIV infection Diseases 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 206010001513 AIDS related complex Diseases 0.000 description 2
- 206010061818 Disease progression Diseases 0.000 description 2
- 108010027044 HIV Core Protein p24 Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004970 cd4 cell Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- -1 dipsticks Substances 0.000 description 2
- 230000005750 disease progression Effects 0.000 description 2
- 238000001952 enzyme assay Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010038997 Retroviral infections Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005184 men's health Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000012205 qualitative assay Methods 0.000 description 1
- 238000012206 semi-quantitative assay Methods 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Endocrinology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE326690A IE63418B1 (en) | 1990-09-10 | 1990-09-10 | Progression risk of HIV by assay of dehydroepiandrosterone in body fluid |
| DE4129932A DE4129932A1 (de) | 1990-09-10 | 1991-09-09 | Screening-verfahren und seine anwendung |
| GB9119256A GB2249833B (en) | 1990-09-10 | 1991-09-09 | Progression risk of HIV by assay of dehydroepiandrosterone in body fluid |
| JP3307281A JPH04351964A (ja) | 1990-09-10 | 1991-09-09 | スクリーニング方法およびそれの適用方法 |
| FR9111118A FR2666657A1 (fr) | 1990-09-10 | 1991-09-09 | Methode pour determiner le risque d'evolution d'une infection provoquee par hiv et sa mise en óoeuvre. |
| ITMI912378A IT1255009B (it) | 1990-09-10 | 1991-09-09 | Metodo per la determinazione del rischio di progressione dell' infezione da hiv e relativo kit diagnostico |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE326690A IE63418B1 (en) | 1990-09-10 | 1990-09-10 | Progression risk of HIV by assay of dehydroepiandrosterone in body fluid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IE63418B1 true IE63418B1 (en) | 1995-04-19 |
Family
ID=11038235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE326690A IE63418B1 (en) | 1990-09-10 | 1990-09-10 | Progression risk of HIV by assay of dehydroepiandrosterone in body fluid |
Country Status (6)
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4230684A (en) * | 1978-03-16 | 1980-10-28 | Cornell Research Foundation, Inc. | Method for determining steroids in human body liquids |
| NL194728C (nl) * | 1987-04-16 | 2003-01-07 | Hollis Eden Pharmaceuticals | Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan. |
| EP0456753B1 (en) * | 1989-02-01 | 1994-05-04 | E.I. Du Pont De Nemours And Company | HIV p17 ASSAYS FOR MONITORING DEVELOPMENT OF AIDS |
| JPH02213766A (ja) * | 1989-02-15 | 1990-08-24 | Mochida Pharmaceut Co Ltd | 免疫測定用試薬および免疫測定器具 |
-
1990
- 1990-09-10 IE IE326690A patent/IE63418B1/en not_active IP Right Cessation
-
1991
- 1991-09-09 IT ITMI912378A patent/IT1255009B/it active IP Right Grant
- 1991-09-09 DE DE4129932A patent/DE4129932A1/de not_active Withdrawn
- 1991-09-09 JP JP3307281A patent/JPH04351964A/ja active Pending
- 1991-09-09 FR FR9111118A patent/FR2666657A1/fr active Granted
- 1991-09-09 GB GB9119256A patent/GB2249833B/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GB9119256D0 (en) | 1991-10-23 |
| DE4129932A1 (de) | 1992-03-12 |
| ITMI912378A1 (it) | 1993-03-09 |
| IT1255009B (it) | 1995-10-11 |
| FR2666657A1 (fr) | 1992-03-13 |
| GB2249833B (en) | 1994-09-07 |
| GB2249833A (en) | 1992-05-20 |
| ITMI912378A0 (it) | 1991-09-09 |
| FR2666657B1 (US20100268047A1-20101021-C00003.png) | 1997-02-21 |
| JPH04351964A (ja) | 1992-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6027904A (en) | Platelet count assay using thrombospondin or β-thromboglobulin | |
| JP5744385B2 (ja) | Ｃｖｄ分析 | |
| JP4523587B2 (ja) | Ａ型及びｂ型急性大動脈解離と急性心筋梗塞の鑑別方法及び鑑別用キット | |
| JP3675837B2 (ja) | 診断測定法におけるリウマチ因子干渉の除去方法 | |
| US20160025738A1 (en) | Prognostic marker to determine the risk for early-onset preeclampsia | |
| Nishihara et al. | Comparison of thyroglobulin and thyroid peroxidase antibodies measured by five different kits in autoimmune thyroid diseases | |
| WO1993003381A1 (en) | Assay for free secretory component and methods for monitoring organ rejection | |
| JP2017507317A (ja) | 胎盤成長因子２の選択的測定法 | |
| Yu et al. | Distinction between bacterial and viral infections by serum measurement of human neutrophil lipocalin (HNL) and the impact of antibody selection | |
| Usui et al. | Serum uromodulin is a novel renal function marker in the Japanese population | |
| KR102228440B1 (ko) | 황산화 다당류를 이용한 면역학적 측정법 | |
| JP5952313B2 (ja) | Ｈｉｖ疾病の進行の予後診断法 | |
| JP2018128378A (ja) | 検査方法及び肝内胆管がん用検査試薬 | |
| JP3558645B2 (ja) | 甲状腺自己免疫疾患の臨床診断薬としてのポリクローナルヒト抗−ｈＴｇ自己抗体の使用及び患者血清中での抗−ｈＴｇ自己抗体の検出用添加薬 | |
| Lukens et al. | Comparison of different immunoassays for the detection of antibodies against intrinsic factor and parietal cells | |
| IE63418B1 (en) | Progression risk of HIV by assay of dehydroepiandrosterone in body fluid | |
| US5108891A (en) | Aids assay | |
| JPH11190734A (ja) | クローン病の検査方法および検査用キット | |
| JP2657377B2 (ja) | Ｈｔｌｖ−▲ｉｉｉ▼対する抗体の免疫試験法 | |
| KR920001533B1 (ko) | 인간 폐표면 활성물질의 측정방법 | |
| JPH0772149A (ja) | 肝癌又は肝硬変の診断薬及び診断法 | |
| Wang et al. | Mechanism of heparin interference in detection of LIAISON® Rubella IgM | |
| JP2007093312A (ja) | Ｈ−ｆａｂｐ及びｄ−ダイマーによる急性大動脈解離の鑑別方法および鑑別用キット | |
| JPH11248703A (ja) | 遊離ハプテンの免疫学的測定法 | |
| EP1596198A1 (en) | Method of measuring oxidized ldl-crp complex and measrurement kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |